Stereotactic ablative radiotherapy and immunotherapy for early-stage lung cancer - Authors' reply
- PMID: 39033005
- DOI: 10.1016/S0140-6736(24)00857-2
Stereotactic ablative radiotherapy and immunotherapy for early-stage lung cancer - Authors' reply
Comment on
-
Stereotactic ablative radiotherapy and immunotherapy for early-stage lung cancer.Lancet. 2024 Jul 20;404(10449):240-241. doi: 10.1016/S0140-6736(24)00855-9. Lancet. 2024. PMID: 39033003 No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical